ESSA Pharma to Present at the Oppenheimer 33rd Annual Healthcare Conference
ESSA Pharma Inc. (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on prostate cancer therapies, announced its presentation at the Oppenheimer 33rd Annual Healthcare Conference on March 15, 2023, at 11:20 a.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ESSA Pharma Inc. (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on prostate cancer therapies, announced its presentation at the Oppenheimer 33rd Annual Healthcare Conference on March 15, 2023, at 11:20 a.m. Eastern Time. The event will feature David R. Parkinson, President and CEO, along with COO Peter Virsik and CFO David S. Wood, who will also participate in one-on-one meetings. Investors can access a live webcast through ESSA's website, with an archived version available for 90 days post-event. ESSA aims to develop novel therapies to improve prostate cancer treatment outcomes.
Details
News Market Reaction – EPIX
The recorded move for EPIX in the trading session of this news was -1.55%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, March 8, 2023 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the virtual Oppenheimer 33rd Annual Healthcare Conference on Wednesday, March 15, 2023, at 11:20 a.m. Eastern Time.
David R. Parkinson, President and Chief Executive Officer of ESSA Pharma; Peter Virsik, ESSA's Chief Operating Officer; and David S. Wood, ESSA's Chief Financial Officer, will host and participate in one-on-one meetings.
A live webcast of the Oppenheimer presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-oppenheimer-33rd-annual-healthcare-conference-301765119.html
SOURCE ESSA Pharma Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.